Real-World Incidence and Burden of Adverse Events Among Non-Metastatic Prostate Cancer Patients Treated With Secondary Hormonal Therapies Following Androgen Deprivation Therapy
Journal of Medical Economics - United Kingdom
doi 10.1080/13696998.2019.1705313
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 6, 2020
Authors
Publisher
Informa UK Limited